Home » Topics » BioWorld Science

BioWorld Science
RSS

Cortecs' Helisal granted marketing clearance

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

Dynagen and Ramco Japan sign MycoDot distribution agreement

June 7, 1996

OraSure HIV-1 Western Blot Kit approved

June 7, 1996

AMPLICOR HIV-1 MONITOR granted U.S. approval

June 7, 1996

Diatide products in clinical trials: Techtide P280 and P748

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Sanguine's PHER-02 development

June 7, 1996

Amgen initiates first leptin clinical study

June 7, 1996

NO-1886 in phase II clinical trials

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...